ISDA

Deposition Date 2020-03-23

Release Date 2020-04-29

Last Version Date 2023-10-18

Entry Detail

PDB ID:

6W9H

Keywords:

TRANSFERASE/TRANSFERASE INHIBITOR

Title:

SUBSTITUTED BENZYLOXYTRICYCLIC COMPOUNDS AS RETINOIC ACID-RELATED ORPHAN RECEPTOR GAMMA T AGONISTS

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.25

R-Value Work:

0.19

R-Value Observed:

0.20

Space Group:

P 41 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Nuclear receptor ROR-gamma, Steroid receptor coactivator 1 fusion
Gene (Uniprot):RORC, NCOA1
Chain IDs:A
Chain Length:285
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P51449,Q15788 Pfam ID:PF00104 EC:2.3.1.48

Ligand Molecules

TKJ

Primary Citation

Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (ROR gamma t) agonists.

Harikrishnan, L.S, Gill, P, Kamau, M.G, Qin, L.Y, Ruan, Z, O'Malley, D, Huynh, T, Stachura, S, Cavallaro, C.L, Lu, Z, J-W Duan, J, Weigelt, C.A, Sack, J.S, Ruzanov, M, Khan, J, Gururajan, M, Wong, J.J, Huang, Y, Yarde, M, Li, Z, Chen, C, Sun, H, Borowski, V, Murtaza, A, Fink, B.E.Show

Bioorg.Med.Chem.Lett. 30 127204 127204 (2020)

PMID: 32334911 DOI: 10.1016/j.bmcl.2020.127204

Abstact

Substituted benzyloxy aryl compound 2 was identified as an RORγt agonist. Structure based drug design efforts resulted in a potent and selective tricyclic compound 19 which, when administered orally in an MC38 mouse tumor model, demonstrated a desired pharmacokinetic profile as well as a dose-dependent pharmacodynamic response. However, no perceptible efficacy was observed in this tumor model at the doses investigated.

Legend

Protein

Chemical

Disease

Primary Citation of related structures